Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization -49% Improvement Relative Risk c19early.org/d Aldwihi et al. Vitamin D for COVID-19 Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Retrospective 738 patients in Saudi Arabia (August - October 2020) Higher hospitalization with vitamin D (p=0.0018) Aldwihi et al., Int. J. Environmental Research a.., doi:10.3390/ijerph18105086 Favors vitamin D Favors control
Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia
Aldwihi et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18105086
Aldwihi et al., Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia, International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18105086
May 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective survey-based analysis of 738 COVID-19 patients in Saudi Arabia, showing lower hospitalization with vitamin C, turmeric, zinc, and nigella sativa, and higher hospitalization with vitamin D. For vitamin D, most patients continued prophylactic use. For vitamin C, the majority of patients continued prophylactic use. For nigella sativa, the majority of patients started use during infection. Authors do not specify the fraction of prophylactic use for turmeric and zinc.
risk of hospitalization, 49.3% higher, RR 1.49, p = 0.002, treatment 94 of 259 (36.3%), control 143 of 479 (29.9%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Aldwihi et al., 11 May 2021, retrospective, Saudi Arabia, peer-reviewed, survey, mean age 36.5, 8 authors, study period August 2020 - October 2020, dosage not specified.
Contact: oalmohammed@ksu.edu.sa (corresponding author), 436202414@student.ksu.edu.sa, 441204353@student.ksu.edu.sa, yazeed@ksu.edu.sa, alamrif@ksau-hs.edu.sa, afaleh@ksu.edu.sa, ofantoukh@ksu.edu.sa, aasssiri@moh.gov.sa.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: International Journal of Environmental Research and Public Health Article Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia Leen A. Aldwihi 1,† , Shahd I. Khan 1,2,† , Faisal F. Alamri 3,4 , Yazed AlRuthia 1,5 , Faleh Alqahtani 6 , Omer I. Fantoukh 7 , Ahmed Assiri 8 and Omar A. Almohammed 1, * 1 2 3 4 5 6 7 8   * † Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; 436202414@student.ksu.edu.sa (L.A.A.); 441204353@student.ksu.edu.sa (S.I.K.); yazeed@ksu.edu.sa (Y.A.) Pharmaceutical Care Department, AlNoor Specialist Hospital, Ministry of Health, Makkah 24241, Saudi Arabia Basic Sciences Department, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Jeddah 22384, Saudi Arabia; alamrif@ksau-hs.edu.sa King Abdullah International Medical Research Center, Jeddah 22384, Saudi Arabia Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; afaleh@ksu.edu.sa Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; ofantoukh@ksu.edu.sa General Directorate of Clinical Excellence, Ministry of Health, Riyadh 11176, Saudi Arabia; aasssiri@moh.gov.sa Correspondence: oalmohammed@ksu.edu.sa; Tel.: +966-555-10-4065 Equal contribution. Citation: Aldwihi, L.A.; Khan, S.I.; Alamri, F.F.; AlRuthia, Y.; Alqahtani, F.; Fantoukh, O.I.; Assiri, A.; Almohammed, O.A. Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia. Int. J. Environ. Res. Public Health 2021, 18, 5086. https://doi.org/10.3390/ ijerph18105086 Academic Editor: David Berrigan Received: 13 April 2021 Accepted: 10 May 2021 Published: 11 May 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2021 by the authors. Abstract: The use of traditional medicinal plants in Saudi Arabia stems mainly from consumers’ belief in prophetic medicine. This study was conducted to explore changes in patients’ use of dietary or herbal supplements among individuals infected with COVID-19 before and during infection and the association between herbal or dietary supplements and hospitalization. A cross-sectional, questionnaire-based study was conducted enrolling symptomatic patients who had recently recovered from COVID-19. Data were collected through phone interviews, and McNemar’s test was used to investigate changes to consumption of dietary or herbal supplements before and during infection. Multivariable logistic regression was used to investigate the association between supplements use during patients’ infection and hospitalization. A total of 738 patients were included in this study, of whom 32.1% required hospitalization. About 57% of participants were male with a mean age of 36.5 (±11.9) years. The use of lemon/orange, honey, ginger, vitamin C, and black seed among participants significantly increased during their infection. In contrast, patients using anise, peppermint, and coffee peel before their infection were more likely to stop using them during their infection. In addition, using lemon/orange (p < 0.0001), honey (p = 0.0002), ginger (p = 0.0053), vitamin C (p = 0.0006), black seed (p <..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit